12/12/2005 13:50:37 Molecular Pharmacology, a US company which recently backdoor-listed on Nasdaq through former exploration mining firm Blue Hawk Ventures, has acquired Perth-based Pharmanet Group’s (ASX:PNO) wholly-owned subsidiary Molecular Pharmacology (MPL Australia). More...
